OOIR: Observatory of International Research

Papers

(The median citation count of Seminars in Immunopathology is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-07-01 to 2025-07-01.)

Article	Citations
Learning cell identity in immunology, neuroscience, and cancer	160
Micro-to multi-chimerism: the multiple facets of a singular phenomenon	131
Adaptive immunity, chronic inflammation and the clock	130
Complement & disease: out of the shadow into the spotlight	116
Vascular galectins in tumor angiogenesis and cancer immunity	115
Role of polyamines in intestinal mucosal barrier function	104
Combination immunotherapy with synthetic long peptides and chemotherapy or PD-1 blocker for cancers caused by human papilloma virus type 16	101
Multiparameter single-cell proteomic technologies give new insights into the biology of ovarian tumors	80
Genetics and functional genomics of multiple sclerosis	74
Diseases of blood vessels: Immune system involvement in vasculitis and vasculopathy	71
Regulatory T lymphocytes as a therapy for ischemic stroke	59
The mucosal immune system and IgA nephropathy	55
Correction: Glycoprotein 2 as a gut gate keeper for mucosal equilibrium between inflammation and immunity	52
Immune checkpoint for pregnancy	52
Correction to: Narcolepsy: a model interaction between immune system, nervous system, and sleep-wake regulation	51
IgA glycosylation and immune complex formation in IgAN	49
Genetics of rheumatoid arthritis	47
Narcolepsy: a model interaction between immune system, nervous system, and sleep-wake regulation	43
The role of vaccines in the COVID-19 pandemic: what have we learned?	43
Thromboinflammatory challenges in stroke pathophysiology	39
Cap analysis of gene expression (CAGE) and noncoding regulatory elements	38
Towards multiomic analysis of oral mucosal pathologies	38
Publisher Correction: Epithelial recognition and elimination against aberrant cells	38
The duality of microchimerism and cancer in parous women: a review and evolutionary perspective	38
Clinical relevance of feto-maternal microchimerism in (hematopoietic stem cell) transplantation	37

Immunization of preterm infants: current evidence and future strategies to individualized approaches	35
Cardiovascular disease risk and pathogenesis in systemic lupus erythematosus	35
Gut instincts in neuroimmunity from the eighteenth to twenty-first centuries	35
Are there animal models of IgA nephropathy?	33
The emerging role of complement in neuromuscular disorders	33
The molecular mechanisms of inflammation and scarring in the kidneys of immunoglobulin A nephropathy	32
Single-cell RNA-seq methods to interrogate virus-host interactions	32
The role of microglia in early neurodevelopment and the effects of maternal immune activation	32
Tolerance and autoimmunity in the liver	31
Glucocorticoid circadian rhythms in immune function	29
IgA nephropathy: a perspective for 2021	29
Current treatment of IgA nephropathy	28
TNF in the liver: targeting a central player in inflammation	27
Dyslipidemia and female reproductive failures: perspectives on lipid metabolism and endometrial immune dysregulation	26
CAF-immune cell crosstalk and its impact in immunotherapy	25
Immune biology of NSCLC revealed by single-cell technologies: implications for the development of biomarkers in patients treated with immunotherapy	25
Neuropathogenesis of HIV-1: insights from across the spectrum of acute through long-term treated infection	24
The aging immune system in Alzheimer’s and Parkinson’s diseases	24
Correction to: MAIT cells in liver inflammation and fibrosis	24
Unveiling the immunopathology of stroke: a comprehensive view on brain-immune interaction	24
Revisiting transplant immunology through the lens of single-cell technologies	24
Role of bile acids in inflammatory liver diseases	23
Beyond defence: Immune architects of ovarian health and disease	23
CAR T-cell behavior and function revealed by real-time imaging	22
Local anesthetics and immunotherapy: a novel combination to fight cancer	22
Tissue-resident immunity in the female and male reproductive tract	22
Arginine metabolism in myeloid cells in health and disease	21
Circadian regulation of innate immunity in animals and humans and implications for human disease	21
Mothers and mosquitoes: climate change contributes to the spread of vector-borne pathogens posing a substantial threat to pregnant women	21
Maternal lipids in overweight and obesity: implications for pregnancy outcomes and offspring’s body composition	20
Role of mucosal IgA antibodies as novel therapies to enhance mucosal barriers	20
Complement activation in IgA nephropathy	20
B cells in autoimmune hepatitis: bystanders or central players?	20
Immune compartments at the brain’s borders in health and neurovascular diseases	20
How genetic risk contributes to autoimmune liver disease	19
Mechanisms of vascular inflammation in deficiency of adenosine deaminase 2 (DADA2)	19
Correction to: Cellular senescence in the cholangiopathies: a driver of immunopathology and a novel therapeutic target	19
Beyond direct killing—novel cellular immunotherapeutic strategies to reshape the tumor microenvironment	19
Correction to: Complement in ischaemia–reperfusion injury and transplantation	19
Intertwining roles of circadian and metabolic regulation of the innate immune response	18
Functional interrogation of autoimmune disease genetics using CRISPR/Cas9 technologies and massively parallel reporter assays	18
Role of glia and extracellular matrix in controlling neuroplasticity in the central nervous system	17
Gut microbiota-derived metabolites tune host homeostasis fate	16
Harnessing the liver to induce antigen-specific immune tolerance	16
Tipping the balance: intricate roles of the complement system in disease and therapy	16
Role of alarmins in poststroke inflammation and neuronal repair	16
Riding the storm: managing cytokine-related toxicities in CAR-T cell therapy	16
Proteomics to study cancer immunity and improve treatment	15
Challenges and opportunities in achieving effective regulatory T cell therapy in autoimmune liver disease	15
Circadian rhythms in adaptive immunity and vaccination	14

Neuroimaging is the new “spatial omic”: multi-omic approaches to neuro-inflammation and immuno-thrombosis in acute ischemic stroke	14
Disease pathogenesis and barrier functions regulated by group 3 innate lymphoid cells	14
Single-cell high-dimensional imaging mass cytometry: one step beyond in oncology	14
Glycoprotein 2 as a gut gate keeper for mucosal equilibrium between inflammation and immunity	13
The sweet and the bitter sides of galectin-1 in immunity: its role in immune cell functions, apoptosis, and immunotherapies for cancer with a focus on T cells	13
Intracellular galectin interactions in health and disease	13
Tumor microenvironment antigens	13
COVID-19 Vasculitis and vasculopathy-Distinct immunopathology emerging from the close juxtaposition of Type II Pneumocytes and Pulmonary Endothelial Cells	13
The role of circulating cell-free DNA as an inflammatory mediator after stroke	13
Unveiling the gut-brain axis: structural and functional analogies between the gut and the choroid plexus vascular and immune barriers	13
Mechanisms of vascular damage in ANCA vasculitis	12
The microbiome and IgA nephropathy	12
Novel immunotherapeutic combinations moving forward: the modulation of the immunosuppressive microenvironment	12
Cell therapies for viral diseases: a new frontier	12
Physiological and immunological barriers in the lung	12
The role of the mucosal barrier system in maintaining gut symbiosis to prevent intestinal inflammation	12